E. Grundström

发表

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

K. Blennow, E. Vanmechelen, M. Sjögren, 2002, Dementia and Geriatric Cognitive Disorders.

On Pathophysiological Mechanisms in Amyothrophic Lateral Sclerosis

T. Grundström, E. Grundström, E. Lindholm, 2001 .

High 3H‐vesamicol binding in ALS motor neurons – autoradiographic visualization of hyperactivity?

S. Aquilonius, P. Gillberg, E. Grundström, 2001, Acta neurologica Scandinavica.

GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis

K. Blennow, A. Johansson, H. Askmark, 2000, Neuroreport.

Increased expression of glial cell line-derived neurotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis

S. Aquilonius, H. Askmark, I. Nygren, 1999, Journal of the Neurological Sciences.

TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis

J. Lünemann, K. Wernecke, F. Zipp, 2003, The Lancet.

Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis

T. Wienker, W. Brück, F. Zipp, 2004, Journal of Neuroimmunology.

Decreased CSF-β-Amyloid 42 in Alzheimer’s Disease and Amyotrophic Lateral Sclerosis May Reflect Mismetabolism of β-Amyloid Induced by Disparate Mechanisms

K. Blennow, E. Vanmechelen, M. Sjögren, 2002, Dementia and Geriatric Cognitive Disorders.

Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons

S. Aquilonius, D. Lindholm, E. Grundström, 1999, Acta neurologica Scandinavica.

On Pathophysiological Mechanisms in Amyothrophic Lateral Sclerosis

E. Grundström, 2000 .

CLINICAL NEUROSCIENCE: GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis

K. Blennow, A. Johansson, D. Lindholm, 2022 .